A comparative study of the antipyretic effects of indomethacin and dipyrone in rats

Author(s)

De Souza‚ GEP ; Cardoso‚ RA ; Melo‚ MCC ; Fabricio‚ ASC ; Silva‚ VMS ; Lora‚ M. ; De Brum-Fernandes‚ AJ ; Rae‚ GA ; Ferreira‚ SH ; Zampronio‚ AR

• Document type: Journal article
• Source: Inflammation Research; v. 51, n. 1, p. 24-32, 2002.

Abstract

Objective: Compare the antipyretic effects of dipyrone and indomethacin. Materials and methods: Fever was induced in rats by i. v. LPS or i. c. v. interleukins (IL), prostaglandins (PG), arachidonic acid (AA), pre-formed pyrogenic factor (PFPF), tumour necrosis factor-alpha (TNT-alpha) or corticotrophin releasing hormone (CRH). Dipyrone and indomethacin were administered i.p., arginine vasopressin V-1-receptor antagonist, d(CH2)(5) Tyr(Me)AVP, into the ventral septal area. Cyclooxygenase (COX-1/-2) blocking activity was assessed in transfected COS-7 cells. CRH release from isolated hypothalami was determined by ELISA. Results: Indomethacin or dipyrone reduced LPS, IL-1beta, IL-6 or TNF-alpha induced fever and CRH release from rat hypothalamus. Only dipyrone inhibited IL-8, PFPF or PGF(2alpha) fever. Only indomethacin inhibited fever induced by AA or IL-1beta plus AA. Neither antipyretic affected fever caused by PGE(2) or CRH. d(CH2)(5)Tyr(Me)AVP only blocked antipyresis induced by indomethacin. Dipyrone at a very high concentration (10 mM) inhibited only COX-1, while indomethacin (0.1 muM) blocked COX-1 and COX-2 in COS-7 cells. Conclusion: The antipyretic effect of dipyrone differs from that of indomethacin in that it does not depend on AVP release or inhibition of PG synthesis. (AU)

• FAPESP's process: 97/09837-6 - Mechanisms and mediators involved in the integration of fever and inflammatory responses
• Grantee: Glória Emília Petto de Souza
• Support Opportunities: Research Projects - Thematic Grants